ELAFIBRANOR  NCT02704403


Laboratory : GENFIT

Study Name : RESOLV’IT

Phase 3

Study Number : NCT02704403

Number of patients recruited : 2000

Probability to be under placebo : 33%

Contacts : 

Contact: Alice Roudot, PharmD

alice.roudot@genfit.com


Contact: Charleen Pagel Jue, B.S., RN

Charleen.PagelJue@Genfit.com

DEDICATED WEB SITE HERE









Share on StockTwits

WWW.NASHBIOTECHS.COM  -  Copyright G DIVRY 2015-2016  - Contact and TERMS OF USE